Related by context. Frequent words. (Click for all words.) 75 R sorafenib tablets 75 oncolytic virus therapies 73 sorafenib tablets 73 ® bortezomib 73 MKC# 73 VEGFR2 inhibitor 72 MKC# MT 71 Voreloxin 71 Panzem R 70 oral proteasome inhibitor 70 2 methoxyestradiol 70 developing Zerenex TM 70 refractory chronic lymphocytic 70 deCODE AF TM 70 Other ImmunoGen collaborative 70 www.vivus.com 70 Archexin 69 immunotherapeutic agent 69 Completes Patient Enrollment 69 Empatic TM 69 forodesine 69 XL# XL# XL# XL# 69 www.syntapharma.com 69 Initiates Phase II 69 Phase Ib IIa 68 overactive bladder AA# 68 FOLOTYN ® 68 DNA methyltransferase inhibitors 68 By Katy Burne 68 Panzem R NCD 68 Amgen discovers develops 68 Sapacitabine 68 liposomal formulation 68 Pazopanib 68 GVAX R 68 By RICK KRETZSCHMAR 68 www.BMRN.com 68 By MOISEKAPENDA BOWER 68 PNP inhibitor 68 PSMA ADC 68 By TERRANCE HARRIS 68 candidate ridaforolimus 68 By Priyanka Dayal 68 Regulatory Disclosure 68 includes investigational compounds 68 interferon gamma 1b 68 * Azixa 68 systemic anaplastic large 67 YOUR LOCAL ANIMAL SHELTER 67 R bortezomib 67 By Lisa Eckelbecker 67 Daclizumab 67 PDE4 inhibitor 67 By Laurie Kulikowski 67 ALN PCS 67 sunitinib malate 67 Auxilium transmucosal film 67 XL# XL# 67 PEG SN# 67 Cephalon Oncology 67 www.anadyspharma.com 67 Annamycin 67 By Amy Boerema 67 By Thomas Gryta 67 By MIKE McKIBBIN 67 By WILLIAM KELLY 67 Amrubicin 67 By Tona Kunz 67 By DANIE HARRELSON 67 Genasense ® 67 By HARVEY SIMPSON 67 L Annamycin 67 orBec ® oral beclomethasone 66 ZFP Therapeutics 66 rheumatoid arthritis psoriatic arthritis 66 deforolimus 66 rheumatoid arthritis inflammatory bowel 66 By Matt Arado 66 By Neil Osterweil 66 dermatology therapies 66 Genasense ® oblimersen 66 DONNER METALS LTD 66 Amgen discovers develops manufactures 66 By Shaun Sutner 66 includes iFinix RealTime 66 reformulates existing FDA 66 HGS ETR2 66 Phase Ib II 66 targeted immunotherapies 66 candidate brentuximab vedotin 66 Belimumab 66 cutaneous T 66 unresectable locally advanced 66 thetreatment 66 By JENNIFER RADCLIFFE 66 By LENORA LAKE 66 leading lipid nanoparticle 66 RhuDex ® 66 Meets Primary Endpoint 66 http:/www.mheducation.com 66 D aspartate NMDA receptor